Adjuvant radiotherapy after radical hysterectomy of the cervical cancer - Prognostic factors and complications

被引:43
作者
Chatani, M
Nose, T
Masaki, N
Inoue, T
机构
[1] Osaka Univ, Sch Med, Biomed Res Ctr, Dept Radiat Oncol, Suita, Osaka 565, Japan
[2] Osaka Univ, Sch Med, Osaka Med Ctr Canc & Cardiovasc Dis, Dept Radiat Therapy, Suita, Osaka 565, Japan
关键词
postoperative radiotherapy; cervical cancer; prognostic factors;
D O I
10.1007/BF03038982
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To investigate prognostic factors and complications after radical hysterectomy followed by postoperative radiotherapy for carcinoma of the uterine cervix. Patients and Methods: One hundred twenty-eight patients with Tlb-2b carcinoma of the uterine cervix following radical hysterectomy with bilateral pelvic lymphadenectomy and postoperative radiation therapy were reviewed. Pathologic and treatment variables were assessed by multivariate analysis for local recurrence, distant metastases and cause specific survival. Results: The number of positive nodes (PN) in the pelvis was the strongest predictor of pelvic recurrence and distant metastases. These 2 failure patterns independently affect the cause specific survival. The 5-year cumulative local and distant failure were PN(0): 2% and 12%, PN(1-2): 23% and 25%, PN(2<): 32% and 57%, respectively (p = 0.0029 and p = 0.0051). The 5-year cause specific survival rates were PN(0): 90%, PN(1-2): 59% and PN(2<): 42% (p = 0.0001). The most common complication was lymphedema of the foot experienced by one-half of the patients (5-year: 42%, 10-year: 49%). Conclusion: These results suggest that patients with pathologic Tlb-T2b cervix cancer with pelvic lymph node metastases are at high risk of recurrence or metastases after radical hysterectomy with pelvic lymphadenectomy and postoperative irradiation.
引用
收藏
页码:504 / 509
页数:8
相关论文
共 19 条
[1]   POSTOPERATIVE RADIOTHERAPY IN CARCINOMA OF THE CERVIX - TREATMENT RESULTS AND PROGNOSTIC FACTORS [J].
ATKOVAR, G ;
UZEL, O ;
OZSAHIN, M ;
KOCA, S ;
SAHINLER, I ;
OKKAN, S ;
UZEL, R .
RADIOTHERAPY AND ONCOLOGY, 1995, 35 (03) :198-205
[2]   POTENTIAL PITFALLS IN THE USE OF P-VALUES AND IN INTERPRETATION OF SIGNIFICANCE LEVELS [J].
BECKBORNHOLDT, HP ;
DUBBEN, HH .
RADIOTHERAPY AND ONCOLOGY, 1994, 33 (02) :171-176
[3]   INFLUENCE OF HISTOLOGICAL FEATURES AND TREATMENT ON THE PROGNOSIS OF PATIENTS WITH CERVICAL-CANCER METASTATIC TO PELVIC LYMPH-NODES [J].
BERMAN, ML ;
BERGEN, S ;
SALAZAR, H .
GYNECOLOGIC ONCOLOGY, 1990, 39 (02) :127-131
[4]  
BIANCHI U A, 1988, European Journal of Gynaecological Oncology, V9, P47
[5]  
Chatani M., 1995, Strahlentherapie und Onkologie, V171, P655
[6]  
COX DR, 1972, J R STAT SOC B, V34, P187
[7]   COMBINED RADIOTHERAPY AND SURGERY - LOCAL-CONTROL AND COMPLICATIONS IN EARLY CARCINOMA OF THE UTERINE CERVIX - THE VILLEJUIF EXPERIENCE, 1975-1984 [J].
GERBAULET, AL ;
KUNKLER, IH ;
KERR, GR ;
HAIE, C ;
MICHEL, G ;
PRADE, M ;
LHOMME, C ;
MASSELOT, M ;
ALBANO, M ;
DUTREIX, A ;
CHASSAGNE, D .
RADIOTHERAPY AND ONCOLOGY, 1992, 23 (02) :66-73
[8]  
GONSALEZ DG, 1989, INT J RADIAT ONCOL, V16, P389
[9]   IS PROPHYLACTIC PARA-AORTIC IRRADIATION WORTHWHILE IN THE TREATMENT OF ADVANCED CERVICAL-CARCINOMA - RESULTS OF A CONTROLLED CLINICAL-TRIAL OF THE EORTC RADIOTHERAPY GROUP [J].
HAIE, C ;
PEJOVIC, MH ;
GERBAULET, A ;
HORIOT, JC ;
POURQUIER, H ;
DELOUCHE, J ;
HEINZ, JF ;
BRUNE, D ;
FENTON, J ;
PIZZI, G ;
BEY, P ;
BROSSEL, R ;
PILLEMENT, P ;
VOLTERRANI, F ;
CHASSAGNE, D .
RADIOTHERAPY AND ONCOLOGY, 1988, 11 (02) :101-112
[10]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481